[email protected] or by fax to 202-395-6974, Attention: NIH Desk Officer. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication."> [email protected] or by fax to 202-395-6974, Attention: NIH Desk Officer. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication." /> [email protected] or by fax to 202-395-6974, Attention: NIH Desk Officer. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication." />

80 FR 13878 - Submission for OMB Review; 30-Day Comment Request; Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (NIDA)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 51 (March 17, 2015)

Page Range13878-13879
FR Document2015-06087

Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register Volume 79, No. 250, on December 31, 2014, page 78875, and allowed 60-days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The National Institute on Drug Abuse (NIDA), National Institutes of Health, may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, [email protected] or by fax to 202-395-6974, Attention: NIH Desk Officer. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication.

Federal Register, Volume 80 Issue 51 (Tuesday, March 17, 2015)
[Federal Register Volume 80, Number 51 (Tuesday, March 17, 2015)]
[Notices]
[Pages 13878-13879]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-06087]



[[Page 13878]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Submission for OMB Review; 30-Day Comment Request; Generic 
Clearance for the Collection of Qualitative Feedback on Agency Service 
Delivery (NIDA)

SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork 
Reduction Act of 1995, the National Institutes of Health (NIH) has 
submitted to the Office of Management and Budget (OMB) a request for 
review and approval of the information collection listed below. This 
proposed information collection was previously published in the Federal 
Register Volume 79, No. 250, on December 31, 2014, page 78875, and 
allowed 60-days for public comment. No public comments were received. 
The purpose of this notice is to allow an additional 30 days for public 
comment. The National Institute on Drug Abuse (NIDA), National 
Institutes of Health, may not conduct or sponsor, and the respondent is 
not required to respond to, an information collection that has been 
extended, revised or implemented on or after October 1, 1995, unless it 
displays a currently valid OMB control number.
    Direct Comments to OMB: Written comments and/or suggestions 
regarding the item(s) contained in this notice, especially regarding 
the estimated public burden and associated response time, should be 
directed to the: Office of Management and Budget, Office of Regulatory 
Affairs, [email protected] or by fax to 202-395-6974, 
Attention: NIH Desk Officer.
    Comment Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 30 days 
of the date of this publication.

FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data 
collection plans and instruments, submit comments in writing, or 
request more information on the proposed project, contact: Genevieve 
deAlmeida, Project Clearance Liaison, National Institute on Drug Abuse, 
NIH, 6001 Executive Boulevard, Bethesda, MD 20892-9557, or call non-
toll-free number (301) 594-6802, or Email your request, including your 
address to: [email protected]. Formal requests for additional plans 
and instruments must be requested in writing.
    Proposed Collection: Generic Clearance for the Collection of 
Qualitative Feedback on Agency Service Delivery (NIDA), 0925-0655, 
Expiration Date 3/31/2015, EXTENSION, National Institute on Drug Abuse 
(NIDA).
    Need and Use of Information Collection: The information collected 
under this clearance will be qualitative customer and stakeholder 
feedback information--their perceptions, experiences and expectations 
of services, issues with service, to focus attention on areas where 
communication, training or changes in operations might improve delivery 
of products or services. The information will be useful and will allow 
for collaborative and actionable communications between the Agency and 
its customers and stakeholders, and will contribute directly to 
improving the programs and management of them.
    The information will not yield data that can be generalized to the 
overall population. The information may also be formative for the 
purpose of developing a concept for a new service program or 
dissemination program. The collections may still be eligible for 
submission for other generic mechanisms designed to yield quantitative 
results. The primary objectives are to obtain feedback on programs from 
customers and stakeholders, that would help make positive changes to 
the programs, or to assist in developing a new program or dissemination 
initiative, or to test medical tools and devices for usability, 
feasibility, and pilot testing of survey questionnaires for 
understandability. Data collection methods to be used in these studies 
include web-based and mailed surveys, focus groups, interviews with 
small groups, ad hoc collections at Conferences. The findings will 
provide valuable information to assist in improving programs that serve 
the public, and in developing good tools and devices to serve the 
public. OMB approval is requested for 3 years.
    NIDA will only submit a collection for approval under this generic 
clearance if it meets the following conditions:
     The collections are voluntary;
     The collections are low-burden for respondents (based on 
considerations of total burden hours, total number of respondents, or 
burden-hours per respondent) and are low-cost for both the respondents 
and the Federal Government;
     The collections are non-controversial and do not raise 
issues of concern to other Federal agencies;
     Any collection is targeted to the solicitation of opinions 
from respondents who have experience with the program or may have 
experience with the program in the near future;
     Personally identifiable information (PII) is collected 
only to the extent necessary and is not retained;
     Information gathered will be used only internally for 
general service improvement and program management purposes and is not 
intended for release outside of the agency;
     Information gathered will not be used for the purpose of 
substantially informing influential policy decisions; and
     Information gathered will yield qualitative information; 
the collections will not be designed or expected to yield statistically 
reliable results or used as though the results are generalizable to the 
population of study.
    Feedback collected under this generic clearance provides useful 
information, but it does not yield data that can be generalized to the 
overall population. This type of generic clearance for qualitative 
information will not be used for quantitative information collections 
that are designed to yield reliably actionable results, such as 
monitoring trends over time or documenting program performance. Such 
data uses require more rigorous designs that address: The target 
population to which generalizations will be made, the sampling frame, 
the sample design (including stratification and clustering), the 
precision requirements or power calculations that justify the proposed 
sample size, the expected response rate, methods for assessing 
potential non-response bias, the protocols for data collection, and any 
testing procedures that were or will be undertaken prior to fielding 
the study. Depending on the degree of influence the results are likely 
to have, such collections may still be eligible for submission for 
other generic mechanisms that are designed to yield quantitative 
results.
    As a general matter, information collections will not result in any 
new system of records containing privacy information and will not ask 
questions of a sensitive nature, such as sexual behavior and attitudes, 
religious beliefs, and other matters that are commonly considered 
private.
    An agency may not conduct or sponsor, and a person is not required 
to respond to, a collection of information unless it displays a 
currently valid Office of Management and Budget control number.
    OMB approval is requested for 3 years. There are no costs to 
respondents other than their time. The total estimated annualized 
burden hours are 1,560.

[[Page 13879]]



                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                      Annual
               Type of collection                    Number of     frequency per     Hours per      Total hours
                                                    respondents      response        response
----------------------------------------------------------------------------------------------------------------
Customer outcomes and usability testing.........             900               1           40/60             600
Customer Satisfaction and needs assessment                   600               1           40/60             400
 survey.........................................
Focus Groups....................................             130               1               1             130
Small Discussion Groups.........................             130               1               1             130
Pilot Testing of instruments for applicability               450               1           40/60             300
 among diverse populations......................
----------------------------------------------------------------------------------------------------------------


    Dated: March 11, 2015.
Genevieve deAlmeida,
Project Clearance Liaison, NIDA, NIH.
[FR Doc. 2015-06087 Filed 3-16-15; 8:45 am]
 BILLING CODE 4140-01-P


Current View
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesComments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication.
ContactTo obtain a copy of the data collection plans and instruments, submit comments in writing, or request more information on the proposed project, contact: Genevieve deAlmeida, Project Clearance Liaison, National Institute on Drug Abuse, NIH, 6001 Executive Boulevard, Bethesda, MD 20892-9557, or call non- toll-free number (301) 594-6802, or Email your request, including your
FR Citation80 FR 13878 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR